相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Activation of mTORC2 by Association with the Ribosome
Vittoria Zinzalla et al.
CELL (2011)
Dissecting the role of mTOR: Lessons from mTOR inhibitors
Ryan J. O. Dowling et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice
Junpei Iwasa et al.
CANCER SCIENCE (2010)
mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
David A. Guertin et al.
CANCER CELL (2009)
Supplementation with Branched-chain Amino Acids Inhibits Azoxymethane-induced Colonic Preneoplastic Lesions in Male C57BL/KsJ-db/db Mice
Masahito Shimizu et al.
CLINICAL CANCER RESEARCH (2009)
S6K1 Deficiency Protects Against Apoptosis in Hepatocytes
Agueda Gonzalez-Rodriguez et al.
HEPATOLOGY (2009)
mTOR signaling at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2009)
Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats
Hitoshi Yoshiji et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model
Ruifang Mi et al.
JOURNAL OF GENETICS AND GENOMICS (2009)
Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1
Christian C. Dibble et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cells
Ville Hietakangas et al.
BMC CANCER (2008)
NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations
Violeta Serra et al.
CANCER RESEARCH (2008)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
CD60-Induced Signaling in Human Endothelial Cells Results in mTORC2-and Akt-Dependent Expression of Vascular Endothelial Growth Factor InVitro and In Vivo
Olivier Dormond et al.
JOURNAL OF IMMUNOLOGY (2008)
Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin
Valter Donadon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Rapamycin regulates the phosphorylation of rictor
Argun Akcakanat et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation
Wolfgang Sieghart et al.
TRANSPLANTATION (2007)
Diabetes mellitus and the risk of cancer - Results from a large-scale population-based cohort study in Japan
Manami Inoue et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection
Mei-Shu Lai et al.
HEPATOLOGY (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
Diabetes, insulin, and risk of cancer
R. Schiel et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy
W Sieghart et al.
JOURNAL OF HEPATOLOGY (2006)
Growing roles for the mTOR pathway
DD Sarbassov et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Oral administration of branched-chain amino acids activates the mTOR signal in cirrhotic rat liver
T Matsumura et al.
HEPATOLOGY RESEARCH (2005)
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition
SY Sun et al.
CANCER RESEARCH (2005)
Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis
Y Muto et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis
S Nishitani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
JA Davila et al.
GUT (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system
C Ijichi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
S Nair et al.
HEPATOLOGY (2002)